NCT01613417View on ClinicalTrials.gov

Comparison of Prohance® With Gadovist®/Gadavist™ in Magnetic Resonance Imaging (MRI) of the Brain

PHASE4CompletedINTERVENTIONAL
Enrollment

229

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Brain Disease
Interventions
DRUG

gadoteridol

ProHance 0.1 mmol/kg

DRUG

gadobutrol

Gadovist/Gadavist 0.1 mmol/kg

Trial Locations (1)

07666

Holy Name Medical Center, Teaneck

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY